Abstract | OBJECTIVES: METHODS:
Hypoxia-inducible factor 1alpha, HDAC1, and MTA1 expressions were detected by immunohistochemistry in 39 pancreatic carcinoma patients. The correlations between the expression of HIF-1alpha, HDAC1, or MTA1 and clinical features and the prognosis were analyzed. RESULTS:
Hypoxia-inducible factor 1alpha, HDAC1, and MTA1 positive stainings were found in 41%, 56%, and 31%, respectively. There was no correlation between HIF-1alpha, HDAC1, or MTA1 expression levels and any clinical parameters. The survival rate for patients with HIF-1alpha and HDAC1-positive stainings were significantly lower than for patients with HIF-1alpha and HDAC1-negative stainings. The MTA1 overexpression group did not have a significantly lower prognosis than the MTA1 underexpression group. The survival rate for the HDAC1(+)/MTA1(2-3) group was significantly lower than for the other groups. CONCLUSIONS: These results suggest that HIF-1alpha expression may be regulated through HDAC1/MTA1, which is associated with a poor prognosis for pancreatic carcinoma and indicates that HIF-1alpha and HDAC1/MTA1 are a promising therapeutic target in pancreatic carcinoma treatment.
|
Authors | Kotaro Miyake, Tomoharu Yoshizumi, Satoru Imura, Koji Sugimoto, Erdenebulgan Batmunkh, Hirofumi Kanemura, Yuji Morine, Mitsuo Shimada |
Journal | Pancreas
(Pancreas)
Vol. 36
Issue 3
Pg. e1-9
(Apr 2008)
ISSN: 1536-4828 [Electronic] United States |
PMID | 18362831
(Publication Type: Journal Article)
|
Chemical References |
- HIF1A protein, human
- Hypoxia-Inducible Factor 1, alpha Subunit
- Mta1 protein, human
- Repressor Proteins
- Trans-Activators
- HDAC1 protein, human
- Histone Deacetylase 1
- Histone Deacetylases
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Female
- Histone Deacetylase 1
- Histone Deacetylases
(metabolism)
- Humans
- Hypoxia-Inducible Factor 1, alpha Subunit
(metabolism)
- Immunohistochemistry
- Male
- Middle Aged
- Pancreatic Neoplasms
(metabolism, mortality, pathology, surgery)
- Prognosis
- Repressor Proteins
(metabolism)
- Survival Rate
- Trans-Activators
|